Advisor Partners II’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$1.24M Buy
80,100
+12,802
+19% +$198K 0.05% 410
2023
Q2
$1.06M Buy
67,298
+14,696
+28% +$231K 0.05% 373
2023
Q1
$867K Buy
52,602
+15,163
+41% +$250K 0.05% 380
2022
Q4
$584K Buy
37,439
+8,247
+28% +$129K 0.04% 478
2022
Q3
$379K Buy
+29,192
New +$379K 0.03% 545